HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

GABELLI FUNDS LLC's Holding History (CIK: 0001081407)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 105,700 Value ($000) $7,114 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 122,243 Value ($000) $8,965 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 126,243 Value ($000) $6,567 Avg Close $56.90 Range $47.50 - $70.51
Q1 2025
Shares 116,180 Value ($000) $7,413 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 120,243 Value ($000) $5,749 Avg Close $51.28 Range $42.01 - $62.13
Q3 2024
Shares 112,243 Value ($000) $6,425 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 124,900 Value ($000) $6,540 Avg Close $43.86 Range $37.73 - $53.00
Q1 2024
Shares 125,000 Value ($000) $5,085 Avg Close $37.49 Range $33.15 - $42.64
Q4 2023
Shares 115,000 Value ($000) $4,250 Avg Close $37.66 Range $32.83 - $42.82
Q3 2023
Shares 90,238 Value ($000) $3,447 Avg Close $40.96 Range $35.71 - $45.00
Q2 2023
Shares 83,738 Value ($000) $3,020 Avg Close $34.12 Range $29.85 - $38.80
Q1 2023
Shares 83,738 Value ($000) $3,198 Avg Close $46.91 Range $32.83 - $57.00
Q4 2022
Shares 17,826 Value ($000) $1,014 Avg Close $51.20 Range $39.17 - $59.46
Q3 2022
Shares 15,000 Value ($000) $593 Avg Close $44.20 Range $38.03 - $52.98
Q2 2022
Shares 15,000 Value ($000) $660 Avg Close $43.25 Range $36.95 - $48.58
Q4 2021
Shares 5,000 Value ($000) $201 Avg Close $37.33 Range $31.79 - $41.20